Full Fed. Circ. Asked To Undo Forum Selection Clause Ruling
By Britain Eakin ( March 11, 2022, 5:38 PM EST) -- Sarepta Therapeutics has urged the full Federal Circuit to review a panel decision finding that a forum selection clause in a mutual confidentiality agreement with Nippon Shinyaku Co. barred seven Patent Trial and Appeal Board challenges to a collection of Nippon's genetic therapy patents, saying it conflicts with settled Delaware contract law....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.